These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22878157)

  • 41. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
    Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
    Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.
    Goyal S; Khan AJ; Vicini F; Beitsch PD; Lyden M; Keisch M; Haffty BG
    Ann Surg Oncol; 2009 Sep; 16(9):2450-8. PubMed ID: 19517191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of the Mammosite registry trial with intergroup study E5194.
    Goyal S; Vicini F; Beitsch PD; Kuerer H; Keisch M; Motwani S; Jeruss JS; Lyden M; Haffty BG
    Cancer; 2011 Mar; 117(6):1149-55. PubMed ID: 21381007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CIH-Tokyo experience with breast-conserving surgery without radiotherapy: 6.5 year follow-up results of 1462 patients.
    Kasumi F; Takahashi K; Nishimura S; Iijima K; Miyagi U; Tada K; Makita M; Iwase T; Oguchi M; Yamashita T; Akiyama F; Sakamoto G
    Breast J; 2006; 12(5 Suppl 2):S181-90. PubMed ID: 16958999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
    Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups.
    Zauls AJ; Watkins JM; Wahlquist AE; Brackett NC; Aguero EG; Baker MK; Jenrette JM; Garrett-Mayer E; Harper JL
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):21-9. PubMed ID: 20951508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
    Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
    Benitez PR; Chen PY; Vicini FA; Wallace M; Kestin L; Edmundson G; Gustafson G; Martinez A
    Am J Surg; 2004 Oct; 188(4):355-64. PubMed ID: 15474426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcome after ipsilateral breast tumor recurrence in patients with early-stage breast cancer treated with accelerated partial breast irradiation.
    Shah C; Wilkinson JB; Jawad M; Wobb J; Berry S; Mitchell C; Wallace M; Vicini FA
    Clin Breast Cancer; 2012 Dec; 12(6):392-7. PubMed ID: 23063380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation.
    Shah C; Vicini F; Keisch M; Kuerer H; Beitsch P; Haffty B; Lyden M
    Cancer; 2012 Sep; 118(17):4126-31. PubMed ID: 22252278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early breast cancer with positive margins: excellent local control with an upfront brachytherapy boost.
    Schroeder TM; Liem B; Sampath S; Thompson WR; Longhurst J; Royce M
    Breast Cancer Res Treat; 2012 Jul; 134(2):719-25. PubMed ID: 22588673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial.
    Khan AJ; Vicini F; Beitsch P; Haffty B; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H; Whitacre E; Whitworth P; Fine R
    Ann Surg Oncol; 2009 Jun; 16(6):1612-8. PubMed ID: 19319606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
    Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
    Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
    McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preliminary results with accelerated partial breast irradiation in high-risk breast cancer patients.
    Wilder RB; Curcio LD; Khanijou RK; Eisner ME; Kakkis JL; Chittenden L; Agustin J; Lizarde J; Mesa AV; Macedo JC; Ravera J; Tokita KM
    Brachytherapy; 2010; 9(2):171-7. PubMed ID: 19854114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy.
    Balch GC; Mithani SK; Simpson JF; Kelley MC
    Am Surg; 2005 Jan; 71(1):22-7; discussion 27-8. PubMed ID: 15757052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
    Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G
    Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Importance of margin width in breast-conserving treatment of early breast cancer.
    Bodilsen A; Bjerre K; Offersen BV; Vahl P; Amby N; Dixon JM; Ejlertsen B; Overgaard J; Christiansen P
    J Surg Oncol; 2016 May; 113(6):609-15. PubMed ID: 26991020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.